147 related articles for article (PubMed ID: 31118345)
1. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg
Nagatani M; Kodera T; Suzuki D; Igura S; Fukunaga Y; Kanemitsu H; Nakamura D; Mochizuki M; Kemi M; Tamura K; Kasahara K
Exp Anim; 2019 Nov; 68(4):471-482. PubMed ID: 31118345
[TBL] [Abstract][Full Text] [Related]
2. Background data on NOD/Shi-scid IL-2Rγ
Kasahara K; Fukunaga Y; Igura S; Andoh R; Saito T; Suzuki I; Kanemitsu H; Suzuki D; Goto K; Nakamura D; Mochizuki M; Yasuda M; Inoue R; Tamura K; Nagatani M
J Toxicol Sci; 2017; 42(6):689-705. PubMed ID: 29142168
[TBL] [Abstract][Full Text] [Related]
3. Higher susceptibility of NOD/LtSz-scid Il2rg (-/-) NSG mice to xenotransplanted lung cancer cell lines.
Kanaji N; Tadokoro A; Susaki K; Yokokura S; Ohmichi K; Haba R; Watanabe N; Bandoh S; Ishii T; Dobashi H; Matsunaga T
Cancer Manag Res; 2014; 6():431-6. PubMed ID: 25364273
[TBL] [Abstract][Full Text] [Related]
4. Higher susceptibility of NOG mice to xenotransplanted tumors.
Machida K; Suemizu H; Kawai K; Ishikawa T; Sawada R; Ohnishi Y; Tsuchiya T
J Toxicol Sci; 2009 Feb; 34(1):123-7. PubMed ID: 19182442
[TBL] [Abstract][Full Text] [Related]
5. Incidence of spontaneous lymphomas in non-experimental NOD/Shi-scid, IL-2Rγ
Yasuda M; Ogura T; Goto T; Yagoto M; Kamai Y; Shimomura C; Hayashimoto N; Kiyokawa Y; Shinohara H; Takahashi R; Kawai K
Exp Anim; 2017 Oct; 66(4):425-435. PubMed ID: 28679969
[TBL] [Abstract][Full Text] [Related]
6. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
7. Establishing EGFP congenic mice in a NOD/Shi-scid IL2Rg(null) (NOG) genetic background using a marker-assisted selection protocol (MASP).
Suemizu H; Yagihashi C; Mizushima T; Ogura T; Etoh T; Kawai K; Ito M
Exp Anim; 2008 Oct; 57(5):471-7. PubMed ID: 18946184
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
9. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
[TBL] [Abstract][Full Text] [Related]
10. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
11. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
13. Data on long-term survival of the NOD/Shi-scid IL-2Rγ
Yamashita Y; Sato T; Noishiki K; Kobayashi K; Uchiyama A; Izumi H; Tamura T; Shikamura M; Oinishi Y; Saito M; Kawamata S
J Toxicol Sci; 2021; 46(10):453-469. PubMed ID: 34602530
[TBL] [Abstract][Full Text] [Related]
14. Enhanced development of functional human NK cells in NOD-scid-IL2rg
Aryee KE; Burzenski LM; Yao LC; Keck JG; Greiner DL; Shultz LD; Brehm MA
FASEB J; 2022 Sep; 36(9):e22476. PubMed ID: 35959876
[TBL] [Abstract][Full Text] [Related]
15. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
16. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
17. Pathology of Aging in NOD scid gamma Female Mice.
Santagostino SF; Arbona RJR; Nashat MA; White JR; Monette S
Vet Pathol; 2017 Sep; 54(5):855-869. PubMed ID: 28355107
[TBL] [Abstract][Full Text] [Related]
18. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.
Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J
Dig Dis Sci; 2014 Jun; 59(6):1169-79. PubMed ID: 24798995
[TBL] [Abstract][Full Text] [Related]
19. Characterization of
Kusakawa S; Machida K; Yasuda S; Takada N; Kuroda T; Sawada R; Okura H; Tsutsumi H; Kawamata S; Sato Y
Regen Ther; 2015 Jun; 1():30-37. PubMed ID: 31245439
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
